File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Phacoemulsification vs phacotrabeculectomy in chronic angle-closure glaucoma with cataract complications

TitlePhacoemulsification vs phacotrabeculectomy in chronic angle-closure glaucoma with cataract complications
Authors
Issue Date2010
PublisherAmerican Medical Association. The Journal's web site is located at http://www.archopthalmol.com
Citation
Archives Of Ophthalmology, 2010, v. 128 n. 3, p. 303-311 How to Cite?
AbstractObjective: To compare the complications of phacoemulsification alone vs combined phacotrabeculectomy in chronic angle-closure glaucoma (CACG) with coexisting cataract. Methods: Patients with CACG with coexisting cataract recruited into 2 randomized controlled trials comparing phacoemulsification alone vs combined phacotrabeculectomy were pooled for analysis. The first trial recruited patients with medically controlled intraocular pressure, while the second trial recruited patients with medically uncontrolled intraocular pressure. The 2 trials had otherwise identical study designs. All patients were reviewed every 3 months for 2 years after surgery. The main outcome measure was the surgical complications of phacoemulsification alone vs combined phacotrabeculectomy in CACG eyes with cataract. Results: One hundred twenty-three CACG eyes with cataract from 123 patients were included. Sixty-two CACG eyes were randomized to receive phacoemulsification alone, and 61 eyes had combined phacotrabeculectomy. In the phacoemulsification group, 5 of the 62 CACG eyes (8.1%) had a total of 5 surgical complications. In the combined phacotrabeculectomy group, 16 of the 61 CACG eyes (26.2%) had a total of 19 surgical complications. The difference in the proportion of eyes with 1 or more surgical complications between the 2 treatment groups was statistically significant (P=.007, Pearson χ2 test). There was no statistically significant difference in final visual acuity or glaucomatous progression during the 24-month follow-up. Conclusions: Combined phacotrabeculectomy resulted in significantly more surgical complications than phacoemulsification alone in CACG eyes with coexisting cataract. There was no difference in visual acuity or disease progression between the 2 treatment groups. ©2010 American Medical Association. All rights reserved.
Persistent Identifierhttp://hdl.handle.net/10722/176483
ISSN
2014 Impact Factor: 4.399
References

 

DC FieldValueLanguage
dc.contributor.authorTham, CCYen_US
dc.contributor.authorKwong, YYYen_US
dc.contributor.authorLeung, DYLen_US
dc.contributor.authorLam, SWen_US
dc.contributor.authorLi, FCHen_US
dc.contributor.authorChiu, TYHen_US
dc.contributor.authorChan, JCHen_US
dc.contributor.authorLam, DSCen_US
dc.contributor.authorLai, JSMen_US
dc.date.accessioned2012-11-26T09:11:43Z-
dc.date.available2012-11-26T09:11:43Z-
dc.date.issued2010en_US
dc.identifier.citationArchives Of Ophthalmology, 2010, v. 128 n. 3, p. 303-311en_US
dc.identifier.issn0003-9950en_US
dc.identifier.urihttp://hdl.handle.net/10722/176483-
dc.description.abstractObjective: To compare the complications of phacoemulsification alone vs combined phacotrabeculectomy in chronic angle-closure glaucoma (CACG) with coexisting cataract. Methods: Patients with CACG with coexisting cataract recruited into 2 randomized controlled trials comparing phacoemulsification alone vs combined phacotrabeculectomy were pooled for analysis. The first trial recruited patients with medically controlled intraocular pressure, while the second trial recruited patients with medically uncontrolled intraocular pressure. The 2 trials had otherwise identical study designs. All patients were reviewed every 3 months for 2 years after surgery. The main outcome measure was the surgical complications of phacoemulsification alone vs combined phacotrabeculectomy in CACG eyes with cataract. Results: One hundred twenty-three CACG eyes with cataract from 123 patients were included. Sixty-two CACG eyes were randomized to receive phacoemulsification alone, and 61 eyes had combined phacotrabeculectomy. In the phacoemulsification group, 5 of the 62 CACG eyes (8.1%) had a total of 5 surgical complications. In the combined phacotrabeculectomy group, 16 of the 61 CACG eyes (26.2%) had a total of 19 surgical complications. The difference in the proportion of eyes with 1 or more surgical complications between the 2 treatment groups was statistically significant (P=.007, Pearson χ2 test). There was no statistically significant difference in final visual acuity or glaucomatous progression during the 24-month follow-up. Conclusions: Combined phacotrabeculectomy resulted in significantly more surgical complications than phacoemulsification alone in CACG eyes with coexisting cataract. There was no difference in visual acuity or disease progression between the 2 treatment groups. ©2010 American Medical Association. All rights reserved.en_US
dc.languageengen_US
dc.publisherAmerican Medical Association. The Journal's web site is located at http://www.archopthalmol.comen_US
dc.relation.ispartofArchives of Ophthalmologyen_US
dc.subject.meshAgeden_US
dc.subject.meshAged, 80 And Overen_US
dc.subject.meshCataract - Complications - Therapyen_US
dc.subject.meshChronic Diseaseen_US
dc.subject.meshDisease Progressionen_US
dc.subject.meshFemaleen_US
dc.subject.meshGlaucoma, Angle-Closure - Complications - Surgeryen_US
dc.subject.meshHumansen_US
dc.subject.meshIntraocular Pressure - Physiologyen_US
dc.subject.meshIntraoperative Complicationsen_US
dc.subject.meshMaleen_US
dc.subject.meshMiddle Ageden_US
dc.subject.meshPhacoemulsification - Adverse Effectsen_US
dc.subject.meshPostoperative Complicationsen_US
dc.subject.meshTrabeculectomy - Adverse Effectsen_US
dc.subject.meshTreatment Outcomeen_US
dc.subject.meshVisual Acuity - Physiologyen_US
dc.titlePhacoemulsification vs phacotrabeculectomy in chronic angle-closure glaucoma with cataract complicationsen_US
dc.typeArticleen_US
dc.identifier.emailLai, JSM: laism@hku.hken_US
dc.identifier.authorityLai, JSM=rp00295en_US
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.doi10.1001/archophthalmol.2010.12en_US
dc.identifier.pmid20212200-
dc.identifier.scopuseid_2-s2.0-77749338093en_US
dc.identifier.hkuros181739-
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-77749338093&selection=ref&src=s&origin=recordpageen_US
dc.identifier.volume128en_US
dc.identifier.issue3en_US
dc.identifier.spage303en_US
dc.identifier.epage311en_US
dc.identifier.eissn1538-3601-
dc.publisher.placeUnited Statesen_US
dc.identifier.scopusauthoridTham, CCY=7006081241en_US
dc.identifier.scopusauthoridKwong, YYY=8614665700en_US
dc.identifier.scopusauthoridLeung, DYL=13309931100en_US
dc.identifier.scopusauthoridLam, SW=7402279310en_US
dc.identifier.scopusauthoridLi, FCH=24779764500en_US
dc.identifier.scopusauthoridChiu, TYH=7202210389en_US
dc.identifier.scopusauthoridChan, JCH=26024354100en_US
dc.identifier.scopusauthoridLam, DSC=35500200200en_US
dc.identifier.scopusauthoridLai, JSM=7401939748en_US

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats